Page 3 - புஜிஃபில்ம் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Japan review of Avigan says efficacy for COVID-19 treatment inconclusive -Kyodo Reuters 17/12/2020 © Reuters/KIM KYUNG-HOON Fujifilm Holdings logos are pictured ahead of its news conference in Tokyo TOKYO (Reuters) - Japanese health authorities say it is difficult to determine the efficacy of Fujifilm Holdings Corp s antiviral drug Avigan as a treatment for COVID-19, Kyodo News reported on Thursday. Fujifilm has been seeking approval for the drug in Japan since October after its late-stage study showed faster recovery time for patients with non-severe symptoms. In its latest assessment, the Pharmaceuticals and Medical Devices Agency raised several concerns, including the fact that doctors were aware which patients had received the drug or a placebo, Kyodo said, citing government sources. The assessment also acknowledged, however, that approving it for COVID-19 would be meaningful as treatment options were limited, Kyodo said.

United statesStephen coatesFujifilm holdingDevices agencyFujifilm holdings corpKyodo newsMedical devices agencyChang ran kimஒன்றுபட்டது மாநிலங்களில்ஸ்டீபன் பூச்சுகள்புஜிஃபில்ம் வைத்திருத்தல்புஜிஃபில்ம் ஹோல்டிங்ஸ் கார்ப்கியோடோ செய்திசாங் ஓடியது கிம்